Muhlenkamp & Co’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-15,810
Closed -$18K 58
2016
Q1
$18K Sell
15,810
-1,675
-10% -$1.91K 0.01% 47
2015
Q4
$21K Buy
17,485
+1,675
+11% +$2.01K 0.01% 51
2015
Q3
$25K Buy
15,810
+3,225
+26% +$5.1K 0.01% 57
2015
Q2
$26K Buy
+12,585
New +$26K 0.01% 61